His main research concerns Microbiology, Escherichia coli, Klebsiella pneumoniae, Internal medicine and Antibacterial agent. His Microbiology research includes elements of Plasmid, Molecular epidemiology and Enterobacteriaceae. Álvaro Pascual has researched Enterobacteriaceae in several fields, including Bacteria and Virology.
Many of his research projects under Internal medicine are closely connected to Context with Context, tying the diverse disciplines of science together. His research integrates issues of Mutation, Cefoxitin and Porin in his study of Antibacterial agent. His Drug resistance research integrates issues from Ciprofloxacin and Multilocus sequence typing.
His primary areas of study are Microbiology, Escherichia coli, Antibacterial agent, Klebsiella pneumoniae and Antimicrobial. His Microbiology research is multidisciplinary, incorporating elements of Plasmid, Enterobacteriaceae and Acinetobacter baumannii. His work carried out in the field of Escherichia coli brings together such families of science as Mutant, Fosfomycin, Bacteria, Drug resistance and Virulence.
His studies in Antibacterial agent integrate themes in fields like Extracellular and Intracellular. His Antimicrobial research includes themes of Antibiotics, Antibiotic resistance and Intensive care medicine. His Antibiotic resistance research focuses on Internal medicine and how it connects with Surgery.
Microbiology, Internal medicine, Klebsiella pneumoniae, Acinetobacter baumannii and Escherichia coli are his primary areas of study. His studies deal with areas such as Plasmid and Mutant as well as Microbiology. Internal medicine is closely attributed to Bacteremia in his study.
His work on Enterobacter cloacae as part of general Klebsiella pneumoniae study is frequently linked to Context, bridging the gap between disciplines. The study incorporates disciplines such as clone, Quorum sensing, Quorum Quenching and Acinetobacter in addition to Acinetobacter baumannii. His study in Escherichia coli is interdisciplinary in nature, drawing from both Ciprofloxacin, Broth microdilution, Drug resistance and Chromosomal mutations.
The scientist’s investigation covers issues in Microbiology, Klebsiella pneumoniae, Antibiotic resistance, Internal medicine and Acinetobacter baumannii. He has included themes like Ceftazidime and Avibactam in his Microbiology study. The concepts of his Klebsiella pneumoniae study are interwoven with issues in Enterobacteriaceae, Multilocus sequence typing, Sepsis and Pneumonia.
His Antibiotic resistance study incorporates themes from Ciprofloxacin, Biofilm, SOS response, SOS Response and Quinolone. His Internal medicine research is multidisciplinary, relying on both Bacteremia and Fosfomycin. Álvaro Pascual combines subjects such as Infectivity, clone, Gene and Quorum Quenching with his study of Acinetobacter baumannii.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quinolone resistance from a transferable plasmid
Luis Martínez-Martínez;Alvaro Pascual;George A Jacoby.
The Lancet (1998)
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial
Shamir R. Mehta;Salim Yusuf;Rafael Díaz;Jun Zhu.
Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients
Jesús Rodríguez-Baño;Maria Dolores Navarro;Luisa Romero;Luis Martínez-Martínez.
Journal of Clinical Microbiology (2004)
A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients
Ronen Ben-Ami;Jesús Rodríguez-Baño;Hande Arslan;Johann D D Pitout.
Clinical Infectious Diseases (2009)
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Jesús Rodríguez-Baño;Juan C. Alcalá;Jose M. Cisneros;Fabio Grill.
JAMA Internal Medicine (2008)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty;Nouri L. Ben Zakour;Mitchell Stanton-Cook;Elizabeth Skippington.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
Jesús Rodríguez-Baño;Belén Gutiérrez-Gutiérrez;Isabel Machuca;Alvaro Pascual.
Clinical Microbiology Reviews (2018)
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Jesús Rodríguez-Baño;María Dolores Navarro;Pilar Retamar;Encarnación Picón.
Clinical Infectious Diseases (2012)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh.
Lancet Infectious Diseases (2017)
Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesuús Rodríguez-Baño;Encarnación Picón;Paloma Gijón;José Ramón Hernández.
Clinical Infectious Diseases (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: